Lectin from Crataeva tapia Bark Improves Tissue Damages and Plasma Hyperglycemia in Alloxan-Induced Diabetic Mice

Figure 1

Fasting serum glucose levels in diabetic mice after treatment with CrataBL. CG: control group; DNT: diabetic nontreated; DT10: diabetic treated with CrataBL (10 mg/kg); DT20: diabetic treated with CrataBL (20 mg/kg); DIT: diabetic treated with insulin (10 mg/kg). ^∗𝑃<0.05 versus CG; ^†𝑃<0.05 versus DNT; ^‡𝑃<0.05 versus DIT.